ANI Pharmaceuticals this week announced Food and Drug Administration approval to produce a delayed-release form of naproxen, the main ingredient in Aleve pain reliever. Naproxen treats moderate pain ...

This was a 13-week, randomized, double-blind study where 810 patients with hip OA received either placebo, naproxen 500 mg twice daily, or naproxcinod 750 mg twice daily. Patients were followed for ...

NEW ORLEANS, LA — A long-awaited trial suggests the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib has similar cardiovascular safety as naproxen and ibuprofen in arthritis patients at ...